Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Randal H. Henderson, Curtis M. Bryant, R. Charles Nichols, William M. Mendenhall, Bradford S. Hoppe, Zhong Su, Christopher G. Morris & Nancy P. Mendenhall. (2022) Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer. Acta Oncologica 61:4, pages 468-477.
Read now
Read now
R. Charles Nichols, Christopher G. Morris, Curtis Bryant, Bradford S. Hoppe, Randal H. Henderson, William M. Mendenhall, Zuofeng Li, Joseph A. Costa, Christopher R. Williams & Nancy P. Mendenhall. (2019) Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer. Cancer Investigation 37:2, pages 85-89.
Read now
Read now
Michael D. Chuong, William Hartsell, Gary Larson, Henry Tsai, George E. Laramore, Carl J. Rossi, J. Ben Wilkinson, Adeel Kaiser & Carlos Vargas. (2018) Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial. Acta Oncologica 57:3, pages 368-374.
Read now
Read now
Articles from other publishers (27)
Robert W. Gao, Jiasen Ma, Thomas M. Pisansky, Jon J. Kruse, Bradley J. Stish, Roman O. Kowalchuk, Brendan P. McMenomy, Mark R. Waddle, Ryan M. Phillips, Richard Choo & Brian J. Davis. (2024) Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate Cancer. International Journal of Particle Therapy 12, pages 100015.
Crossref
Crossref
Shaakir Hasan, Vivek Verma, Ananya Raghavan, Stephen Abel, Rodney E. Wegner, J. Isabelle Choi, Robert H. Press, Arpit Chhabra & Charles B. SimoneIIII. (2024) Differences in Patterns of Care and Referral Between Proton and Photon Therapy. International Journal of Particle Therapy 11, pages 100005.
Crossref
Crossref
Alexander Lukez, Elizabeth Handorf, Nancy P. Mendenhall, Randal H. Henderson, Bradley J. Stish, Brian J. Davis, Mark Hallman, Eric M. Horwitz, Neha Vapiwala & Jessica Karen Wong. (2023) A pooled patient‐reported outcomes analysis of moderately hypofractionated proton beam therapy and photon‐based intensity modulated radiation therapy for low‐ or intermediate‐risk prostate cancer. The Prostate 84:4, pages 395-402.
Crossref
Crossref
Maria Chiara Lo Greco, Giulia Marletta, Giorgia Marano, Alessandro Fazio, Emanuele Buffettino, Arianna Iudica, Rocco Luca Emanuele Liardo, Roberto Milazzotto, Pietro Valerio Foti, Stefano Palmucci, Antonio Basile, Francesco Marletta, Francesco Cuccia, Giuseppe Ferrera, Silvana Parisi, Antonio Pontoriero, Stefano Pergolizzi & Corrado Spatola. (2023) Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives. Medicina 59:6, pages 1144.
Crossref
Crossref
William W. Wong, David W. Hillman, Thomas B. Daniels, Carlos E. Vargas, Jean Claude Rwigema, Kimberly S. Corbin, Sameer R. Keole, Kenneth W. Merrell, Bradley J. Stish, Thomas M. Pisansky, Brian J. Davis, Cecilia M. Mitchell & Richard Choo. (2022) A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient‐reported quality of life. The Prostate 82:14, pages 1338-1345.
Crossref
Crossref
Matthew Forsthoefel, Ryan Hankins, Elizabeth Ballew, Cara Frame, David DeBlois, Dalong Pang, Pranay Krishnan, Keith Unger, Keith Kowalczyk, John Lynch, Anatoly Dritschilo, Sean P. Collins & Jonathan W. Lischalk. (2022) Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons. International Journal of Particle Therapy 9:1, pages 28-41.
Crossref
Crossref
Cameron S. ThorpeMDMD, Ronik S. BhangooMDMD, Justin D. AndersonMDMD, Jiajian (Jason) ShenPhDPhD & Carlos E. VargasMDMD. 2022. Principles and Practice of Particle Therapy. Principles and Practice of Particle Therapy
383
410
.
Alexandre Santos, Scott Penfold, Peter Gorayski & Hien Le. (2022) The Role of Hypofractionation in Proton Therapy. Cancers 14:9, pages 2271.
Crossref
Crossref
Yao-Yu Wu & Kang-Hsing Fan. (2022) Proton therapy for prostate cancer: current state and future perspectives. The British Journal of Radiology 95:1131.
Crossref
Crossref
Koichiro Nakajima, Hiromitsu Iwata, Yukiko Hattori, Kento Nomura, Kensuke Hayashi, Toshiyuki Toshito, Yukihiro Umemoto, Shingo Hashimoto, Hiroyuki Ogino & Yuta Shibamoto. (2022) Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer. Cancers 14:3, pages 517.
Crossref
Crossref
Curtis M. Bryant, Randal H. Henderson, R. Charles Nichols, William M. Mendenhall, Bradford S. Hoppe, Carlos E. Vargas, Thomas B. Daniels, C. Richard Choo, Rahul R. Parikh, Huan Giap, Jerry D. Slater, Neha Vapiwala, William Barrett, Akash Nanda, Mark V. Mishra, Seungtaek Choi, Jay J. Liao & Nancy P. Mendenhall. (2021) Consensus Statement on Proton Therapy for Prostate Cancer. International Journal of Particle Therapy 8:2, pages 1-16.
Crossref
Crossref
Jiří Kubeš, Alexandra Haas, Vladimír Vondráček, Michal Andrlík, Matěj Navrátil, Silvia Sláviková, Pavel Vítek, Kateřina Dědečková, Jana Prausová, Barbora Ondrová, Štěpán Vinakurau, Alexander Grebenyuk, Tomáš Doležal, Barbora Velacková & Jozef Rosina. (2021) Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes. International Journal of Radiation Oncology*Biology*Physics 110:4, pages 1090-1097.
Crossref
Crossref
Neha Vapiwala, J. Karen Wong, Elizabeth Handorf, Jonathan Paly, Amardeep Grewal, Rahul Tendulkar, Devon Godfrey, David Carpenter, Nancy P. Mendenhall, Randal H. Henderson, Bradley J. Stish, Carlos Vargas, Joseph K. Salama, Brian J. Davis & Eric M. Horwitz. (2021) A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients. International Journal of Radiation Oncology*Biology*Physics 110:4, pages 1082-1089.
Crossref
Crossref
Yuan Liu, Sagar A. Patel, Ashesh B. Jani, Theresa W. Gillespie, Pretesh R. Patel, Karen D. Godette, Bruce W. Hershatter, Joseph W. Shelton & Mark W. McDonald. (2021) Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy. Clinical Genitourinary Cancer 19:3, pages 255-266.e7.
Crossref
Crossref
Adam C. Mueller & Thomas J. Pugh. 2021. Radiation Therapy for Genitourinary Malignancies. Radiation Therapy for Genitourinary Malignancies
169
187
.
Elisa Thomas, Tobias Hölscher & Mechthild Krause. (2020) Erhaltene sexuelle Funktion nach hochdosierter bildgestützter Protonentherapie. InFo Hämatologie + Onkologie 23:5, pages 32-33.
Crossref
Crossref
Elisa Thomas, Tobias Hölscher & Mechthild Krause. (2020) Erhaltene sexuelle Funktion nach hochdosierter bildgestützter Protonentherapie des ProstatakarzinomsPreserve sexual function after high-dose image-guided proton therapy for prostate cancer. Strahlentherapie und Onkologie 196:3, pages 293-295.
Crossref
Crossref
Jiří Kubeš, Vladimir Vondráček, Michal Andrlik, Matěj Navrátil, Silvia Sláviková, Pavel Vítek, Jozef Rosina, Jitka Abrahámová, Jana Prausová, Alexander Grebenyuk & Kateřina Dědečková. (2019) Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results. Journal of Medical Imaging and Radiation Oncology 63:6, pages 829-835.
Crossref
Crossref
Thomas J. Quinn & Daniel Hamstra. (2019) Hypofractionation in Prostate Cancer Using Proton Beam. International Journal of Radiation Oncology*Biology*Physics 105:4, pages 723-726.
Crossref
Crossref
Amardeep S. Grewal, Caitlin Schonewolf, Eun Jeong Min, Hann-Hsiang Chao, Stefan Both, Sarah Lam, Susan Mazzoni, Justin Bekelman, John Christodouleas & Neha Vapiwala. (2019) Four-Year Outcomes From a Prospective Phase II Clinical Trial of Moderately Hypofractionated Proton Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 105:4, pages 713-722.
Crossref
Crossref
France Carrier, Yixiang Liao, Nancy Mendenhall, Patrizia Guerrieri, Dorin Todor, Anis Ahmad, Michael Dominello, Michael C. Joiner & Jay Burmeister. (2019) Three Discipline Collaborative Radiation Therapy (3DCRT) Special Debate: I would treat prostate cancer with proton therapy. Journal of Applied Clinical Medical Physics 20:7, pages 7-14.
Crossref
Crossref
Jason M. Slater, Jerry D. Slater, Joseph I. Kang, Ivan C. Namihas, B. Rodney Jabola, Kelcie Brown, Roger Grove, Cherie Watt & David A. Bush. (2019) Hypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda University. International Journal of Particle Therapy 6:1, pages 1-9.
Crossref
Crossref
Adam L. Holtzman, Curtis M. Bryant, Nancy P. Mendenhall, William M. Mendenhall, R. Charles Nichols, Randal H. Henderson, Nicholas Figura, Christopher G. Morris, Christopher R. Williams, Zoufeng Li & Bradford S. Hoppe. (2019) Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate Cancer. Radiotherapy and Oncology 134, pages 204-210.
Crossref
Crossref
Amandeep S. Taggar, Paveen Mann & Michael J. Zelefsky. 2019. Stereotactic Radiosurgery for Prostate Cancer. Stereotactic Radiosurgery for Prostate Cancer
93
110
.
Arpit M. Chhabra, Melissa A. Frick, Tejan Diwanji, Jason K. Molitoris & Charles B. SimoneIIII. 2019. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy
217
233
.
Man Hu, Liyang Jiang, Xiangli Cui, Jianguang Zhang & Jinming Yu. (2018) Proton beam therapy for cancer in the era of precision medicine. Journal of Hematology & Oncology 11:1.
Crossref
Crossref
Hiromitsu Iwata, Hitoshi Ishikawa, Masaru Takagi, Tomoaki Okimoto, Sigeyuki Murayama, Tetsuo Akimoto, Hitoshi Wada, Takeshi Arimura, Yoshitaka Sato, Masayuki Araya, Jun‐etsu Mizoe, Masahiko Gosho, Katsumasa Nakamura, Hiroki Shirato & Hideyuki Sakurai. (2018) Long‐term outcomes of proton therapy for prostate cancer in Japan: a multi‐institutional survey of the Japanese Radiation Oncology Study Group. Cancer Medicine 7:3, pages 677-689.
Crossref
Crossref